SEATTLE, WA–(Marketwired – Jul 6, 2017) – In the news release, “Tetra Bio-Pharma: Defending Validating Smoked Cannabis — CFN Media,” issued earlier today by CFN Media, we are advised by the company that the Tetra Bio-Pharma Inc. ticker in the first paragraph should read “(OTCQB: TBPMF)” rather than “(OTC: GRPOF)” as originally issued. Complete corrected text follows.
Tetra Bio-Pharma: Defending Validating Smoked Cannabis — CFN Media
SEATTLE, WA — Jul 6, 2017 — CFN Media Group (“CannabisFN”), the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an exclusive interview and article discussing Tetra Bio-Pharma Inc. (CNSX: TBP) (OTCQB: TBPMF) and its clinical approach to defending the use of dried marijuana to treat patients in Canada.
Cannabis has been consumed via smoking for several hundred years, but the rise and fall of the tobacco industry has caused concern among the public. While tobacco